FIELD: medicine. SUBSTANCE: method involves determination of erythrocyte volume simultaneously with plasma volume in tissue by preliminary intravenous administration of albumin labeled with iodine-125 in organism (30-60 kBq/100 g body mass) following by recording of radioactivity level in tissue and blood plasma. EFFECT: enhanced precision of method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING THE VOLUME OF ERYTHROCYTES IN BIOLOGICAL TISSUES | 0 |
|
SU1727067A1 |
| METHOD FOR ERYTHROPOIETIN PREPARATION | 0 |
|
SU1651909A1 |
| METHOD OF DETERMINATION QUANTITY OF BLOOD IN PORTION OF URINE | 1991 |
|
RU2013777C1 |
| NEW CLASS OF PHYSIOLOGICALLY ACTIVE GLYCOPROTEINS | 2000 |
|
RU2223781C2 |
| MEDICAL AGENTS DELIVERY TO THE CENTRAL NERVOUS SYSTEM | 2011 |
|
RU2626514C2 |
| COMPOSITION FOR INDUCTION OF SPECIFIC IMMUNOLOGICAL TOLERANCE | 2010 |
|
RU2782223C2 |
| METHOD OF ESTIMATING PROCESS ACTIVITY IN NEPHRITIS PATIENT WITH PRESERVED KIDNEY FUNCTION | 2002 |
|
RU2214603C1 |
| APPLICATION OF TIMOSAPONIN B-II IN MAKING DRUG OR PRODUCT FOR STROKE PREVENTION AND TREATMENT | 2005 |
|
RU2376993C2 |
| METHOD FOR DETERMINATION OF VOLUME OF CIRCULATING BLOOD | 0 |
|
SU1657149A1 |
| RADIOPHARMACEUTICAL COMPOSITION FOR DIGESTIVE SYSTEM DISEASE DIAGNOSTICS | 2006 |
|
RU2333772C2 |
